[go: up one dir, main page]

CN107041921A - A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation - Google Patents

A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation Download PDF

Info

Publication number
CN107041921A
CN107041921A CN201710096844.4A CN201710096844A CN107041921A CN 107041921 A CN107041921 A CN 107041921A CN 201710096844 A CN201710096844 A CN 201710096844A CN 107041921 A CN107041921 A CN 107041921A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
motherwort
eucommia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710096844.4A
Other languages
Chinese (zh)
Inventor
黄木土
郭会平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital of Guangzhou Military Command
Original Assignee
General Hospital of Guangzhou Military Command
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital of Guangzhou Military Command filed Critical General Hospital of Guangzhou Military Command
Priority to CN201710096844.4A priority Critical patent/CN107041921A/en
Publication of CN107041921A publication Critical patent/CN107041921A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533Leonurus (motherwort)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/46Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2068Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a kind of Chinese medicine composition, in parts by mass, the bulk drug proportioning of the active constituents of medicine of the Chinese medicine composition is:100~500 parts of motherwort, 20~40 parts of Radix Angelicae Sinensis, interrupted 15~20 parts, 10~20 parts of the bark of eucommia, 10~20 parts of Chinese yam, 40~50 parts of donkey-hide gelatin.The pharmaceutical composition has warm kidney blood-nourishing, blood-nourishing and battalion, and effect promoting blood circulation and removing blood stasis goes for the symptoms such as hypoplasia of uterus, irregular menstruation, amenorrhoea.

Description

一种用于治疗子宫发育不良、月经不调等症的组合物A composition for treating uterine dysplasia, irregular menstruation and other diseases

技术领域technical field

本发明涉及中药领域,特别涉及到一种治疗子宫发育不良、月经不调等症的组合物。The invention relates to the field of traditional Chinese medicine, in particular to a composition for treating uterine dysplasia, irregular menstruation and the like.

背景技术Background technique

月经病是妇科常见疾病,如经期提前、错后,痛经、闭经、崩漏都属于这个范围。月经病的病因有外感和内伤两方面,外感以寒、热、湿为主,当这些外邪侵入人体,影响营卫气血的周流,致使体弱妇女营卫周流失常,进而影响冲、任二脉,产生月经不调。内伤以忧,思、悲、惊者居多,这些因素往往引起气血失调,冲、任二脉受损,故发生月经疾病。另外因饮食不当也会影响妇女月经,如饮食不节,可损伤脾气;过食辛辣,可使脾胃积热;过食生冷,而伤胃气,这些都影响气血功能,使冲、任受损。临床因患其它急慢性病而引致月经病的也常见。Menstrual disease is a common disease in gynecology, such as early menstruation, missed menstruation, dysmenorrhea, amenorrhea, and metrorrhagia. The etiology of menstrual disease has two aspects: exogenous pathogenic factors and internal injuries. Exogenous pathogenic factors are mainly cold, heat, and dampness. When these exogenous pathogens invade the human body, they will affect the circulation of qi and blood in the body, resulting in abnormal circulation of qi and blood in weak women, which in turn will affect the menstrual cycle. , Ren Ermai, resulting in irregular menstruation. Internal injuries are caused by worries, thoughts, sorrows, and shocks. These factors often cause Qi and blood disorders, and the Chong and Ren channels are damaged, so menstrual diseases occur. In addition, improper diet can also affect women's menstruation, such as improper diet, which can damage the temper; overeating spicy food can cause spleen and stomach to accumulate heat; damage. Clinically, menstrual disorders caused by other acute and chronic diseases are also common.

益母草,又名:蓷、茺蔚、坤草、九重楼、云母草、森蒂,为唇形科、益母草属植物,夏季开花。其干燥地上部分为常用中药,中国大部分地区均产,生用或熬膏用。一年或二年生草本全国大部分地区均有分布,生于山野荒地、田埂、草地等。在夏季生长茂盛花未全开时采摘,味辛苦、凉,活血、祛淤、调经、消水,治疗妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡。益母草有利尿消肿、收缩子宫作用的作用,是历代医家用来治疗妇科病的要药。Motherwort, also known as: Lily, Chiwei, Kuncao, Jiuzhonglou, Mica Grass, Senti, is a plant of the Lamiaceae and the genus Leonurus, which blooms in summer. Its dry aerial part is commonly used in traditional Chinese medicine, and it is produced in most parts of China. It is used raw or boiled for ointment. The annual or biennial herbs are distributed in most parts of the country, and are born in wild lands, fields, grasslands, etc. It is picked in summer when the lush flowers are not in full bloom. It tastes bitter and cool. It can promote blood circulation, remove silt, regulate menstruation, and eliminate water. Next, hematuria, diarrhea, carbuncle sores. Motherwort has diuretic, swelling, and uterine contraction effects, and it is an important medicine used by doctors of all ages to treat gynecological diseases.

为了治疗子宫发育不良、月经不调、闭经等症状,发明一种效果显著的中药配方,是具有十分重要的作用的。In order to treat symptoms such as uterine dysplasia, irregular menstruation, and amenorrhea, it is very important to invent a Chinese medicine formula with remarkable effects.

发明内容Contents of the invention

本发明的目的在于公开一种效果显著的中药组合物的配方。The purpose of the present invention is to disclose the formula of a traditional Chinese medicine composition with remarkable effect.

本发明所采取的技术方案是:The technical scheme that the present invention takes is:

一种中药组合物,其药物活性成分为益母草、当归、续断、杜仲、山药、阿胶。A traditional Chinese medicine composition, the active ingredients of which are Motherwort, Angelica, Dipsacus, Eucommia, Chinese Yam and Ejiao.

优选的,按质量份计,药物活性成分的原料药配比为:益母草100~500份,当归20~40份,断续15~20份,杜仲10~20份,山药10~20份,阿胶40~50份。Preferably, in terms of parts by mass, the raw material ratio of the active ingredients of the medicine is: 100-500 parts of motherwort, 20-40 parts of angelica, 15-20 parts of intermittent, 10-20 parts of Eucommia, 10-20 parts of yam, donkey-hide gelatin 40-50 copies.

进一步优选的,按质量份计,药物活性成分的原料药配比为:益母草250份,当归30份,断续18份,杜仲15份,山药15份,阿胶45份。Further preferably, in terms of parts by mass, the raw material ratio of the active ingredients is: 250 parts of Motherwort, 30 parts of Angelica sinensis, 18 parts of Duzhong, 15 parts of Eucommia ulmoides, 15 parts of Chinese yam, and 45 parts of donkey-hide gelatin.

优选的,该中药组合物为口服试剂。Preferably, the traditional Chinese medicine composition is an oral agent.

优选的,该中药组合物配方可以制备治疗子宫发育不良、月经不调、闭经的药物。Preferably, the traditional Chinese medicine composition formula can prepare medicines for treating uterine dysplasia, irregular menstruation and amenorrhea.

一种制备治疗子宫发育不良、月经不调、闭经药物的方法,其含有步骤:按质量份计,取益母草100~500份,当归20~40份,断续15~20份,杜仲10~20份,山药10~20份,阿胶40~50份,充分混合均匀,趁热加入炼蜜800~1000份,高速搅拌均匀,制丸,即得。A method for preparing a medicine for treating uterine dysplasia, irregular menstruation, and amenorrhea, which comprises the steps of: taking 100-500 parts of motherwort, 20-40 parts of angelica, 15-20 parts of intermittent, and 10-20 parts of Eucommia 10-20 parts of yam, 40-50 parts of donkey-hide gelatin, mix well, add 800-1000 parts of refined honey while hot, stir evenly at high speed, make pills, and get it.

本发明的有益效果是:该药物组合物可以具有抑制抑制缩宫素引起的在体子宫收缩作用,同时能促进子宫内膜增生。可以应用于治疗子宫发育不良、月经不调、闭经等症状。The beneficial effects of the invention are: the pharmaceutical composition can inhibit the uterine contraction caused by oxytocin in vivo, and can promote endometrial hyperplasia at the same time. It can be used to treat symptoms such as uterine dysplasia, irregular menstruation, and amenorrhea.

具体实施方式detailed description

实施例1Example 1

取益母草250g、当归30g、续断18g、杜仲15g、山药15g、阿胶45g,研细,过80~100目筛,混匀,趁热加入炼蜜900g,高速搅拌均匀,制丸,制成每丸3g。Take 250g of Motherwort, 30g of Angelica, 18g of Dipsacus, 15g of Eucommia, 15g of Chinese Yam, and 45g of Ejiao, grind them finely, pass through an 80-100 mesh sieve, mix well, add 900g of refined honey while it is hot, stir evenly at high speed, make pellets, and make each Pill 3g.

实施例2Example 2

取益母草100g、当归40g、续断20g、杜仲20g、山药20g、阿胶50g,研细,过80~100目筛,混匀,趁热加入炼蜜800g,高速搅拌均匀,制丸,制成每丸3g。Take 100g of Motherwort, 40g of Angelica, 20g of Dipsacus, 20g of Eucommia, 20g of Chinese Yam, and 50g of Ejiao, grind them finely, pass through a 80-100 mesh sieve, mix well, add 800g of refined honey while it is hot, stir evenly at high speed, make pellets, and make each Pill 3g.

实施例3Example 3

取益母草200g、当归40g、续断20g、杜仲20g、山药15g、阿胶40g,研细,过80~100目筛,混匀,趁热加入炼蜜1000g,高速搅拌均匀,制丸,制成每丸3g。Take 200g of Motherwort, 40g of Angelica, 20g of Dipsacus, 20g of Eucommia, 15g of Chinese Yam, and 40g of Ejiao, grind them finely, pass through an 80-100 mesh sieve, mix well, add 1000g of refined honey while it is hot, stir evenly at high speed, make pills, and make each Pill 3g.

实施例4Example 4

取益母草300g、当归20g、续断15g、杜仲10g、山药10g、阿胶50g,研细,过80~100目筛,混匀,趁热加入炼蜜900g,高速搅拌均匀,制丸,制成每丸3g。Take 300g of Motherwort, 20g of Angelica, 15g of Dipsacus, 10g of Eucommia, 10g of Chinese Yam, and 50g of Ejiao, grind them finely, pass through an 80-100 mesh sieve, mix well, add 900g of refined honey while it is hot, stir evenly at high speed, make pellets, and make each Pill 3g.

实施例5Example 5

取益母草500g、当归20g、续断15g、杜仲10g、山药10g、阿胶40g,研细,过80~100目筛,混匀,趁热加入炼蜜800g,高速搅拌均匀,制丸,制成每丸3g。Take 500g of Motherwort, 20g of Angelica, 15g of Dipsacus, 10g of Eucommia, 10g of Chinese Yam, and 40g of Ejiao, grind them finely, pass through a 80-100 mesh sieve, mix well, add 800g of refined honey while it is hot, stir evenly at high speed, make pellets, and make each Pill 3g.

实验例Experimental example

1、对小鼠子宫、卵巢发育的影响1. Effects on mouse uterus and ovary development

雌性小鼠50只,体重(11±1)g,随机分为5组,生理盐水组、已烯雌酚组、加味益母丸组(3.6,2.4,1.2g/Kg),加味益母丸为实施例1的配方,除已烯雌酚组皮下注射外,其它各组均灌胃给药,给药量0.0012g/mL,连续给药14d,第15d动物称重后处死,剖取子宫和卵巢,剥离干净其周围的结缔组织,用电子天平称重,并换算成脏器系数,结果见表150 female mice, body weight (11±1) g, were randomly divided into 5 groups, normal saline group, diethylstilbestrol group, modified Yimu pill group (3.6, 2.4, 1.2g/Kg), modified Yimu pill It is the formula of Example 1. Except for the subcutaneous injection of diethylstilbestrol group, all other groups were intragastrically administered at a dose of 0.0012 g/mL. The administration was continued for 14 days. On the 15th day, the animals were weighed and sacrificed, and the uterus was dissected. and ovary, peel off the connective tissue around it, weigh it with an electronic balance, and convert it into organ coefficient, the results are shown in Table 1

表1加味益母丸对小鼠子宫发育的影响(x±s,n=10)Table 1 The effect of Jiawei Yimu Pill on mouse uterus development (x±s, n=10)

注:与对照组比较①P<0.05,②P<0.01(下同)Note: Compared with the control group ①P<0.05, ②P<0.01 (the same below)

结果表明,加味益母丸高、中剂量组能显著增加小鼠子宫重量,而对卵巢增重无影响。2对缩宫素所致大鼠扭体反应的影响The results showed that the high-dose and medium-dose groups of Jiawei Yimu Pill could significantly increase the weight of the mouse uterus, but had no effect on the weight gain of the ovary. 2 Effects on the writhing response of rats induced by oxytocin

雌性大鼠50只,体重(200±20)g,随机分为5组,连续皮下注射已烯雌酚10d(第1日、第10日为0.8mg/只,其余每天注射0.4mg/只),在注射已烯雌酚的第5日开始,连续灌胃给药7d(阿斯匹林给药3d),末次给已烯雌酚24h后,再给1次受试药物,40min后ip缩宫素2μ/只,观察30min内大鼠发生的扭体反应次数(大鼠腹部收缩内凹,躯干与后肢伸展,臂部与侧肢体内旋,为子宫收缩即痛经的指标),结果见表2。50 female rats, body weight (200±20) g, were randomly divided into 5 groups, and continuously subcutaneously injected diethylstilbestrol for 10 days (0.8 mg/rat on the 1st and 10th day, and 0.4 mg/rat every day for the rest) On the 5th day after the injection of diethylstilbestrol, the drug was given by intragastric administration for 7 days continuously (aspirin was given for 3 days). 24 hours after the last dose of diethylstilbestrol, the test drug was administered once again, and the ip contraction was performed 40 minutes later. Uterine 2 μ/rat, observe the number of writhing reactions in rats within 30 minutes (abdominal contraction and indentation of rats, trunk and hind limbs stretch, arms and side limbs inward rotation, which are indicators of uterine contraction or dysmenorrhea), the results are shown in the table 2.

表2加味益母丸对缩宫素所致小鼠扭体反应的影响(x±s,n=10)Table 2 Effect of Jiawei Yimu Pills on the Writhing Response of Mice Caused by Oxytocin (x±s, n=10)

结果表明,加味益母丸高、中剂量组能明显减少小鼠扭体反应次数。The results showed that the high-dose and medium-dose groups of Jiawei Yimu Pill could significantly reduce the number of writhing reactions in mice.

3、对大鼠离体子宫的影响3. Effects on isolated rat uteri

大鼠120~200g,雌性,实验前24h按0.2mg/100g体重皮下注射已烯雌酚促进动物处于动情期,以提高子宫对药物的敏感性。实验开始前将动物处死,剪取2cm长子宫,固定于盛有子宫营养液的麦氏浴槽中(15mL),另一端与张力换能器连接,换能器与电脑相连,调节样品前负荷为1g(从电脑中可以直接量出子宫肌张力),麦氏浴槽中不断通入O2,速度每秒1~2个气泡。待子宫稳定后加入药物,每次换药用营养液冲洗3次,药物浓度为浴槽中最终浓度。观察记录子宫在给药后10min内的最高肌张力和收缩次数,结果见表3Rats 120-200g, female, subcutaneously inject diethylstilbestrol at 0.2mg/100g body weight 24 hours before the experiment to promote the animal to be in estrus, so as to improve the sensitivity of the uterus to the drug. Before the start of the experiment, the animals were killed, and the 2 cm long uterus was cut and fixed in a Maxwellian bath filled with uterine nutrient solution (15 mL). 1g (Uterine muscle tension can be directly measured from the computer), and O 2 is continuously injected into the Maxwell bath at a rate of 1 to 2 bubbles per second. After the uterus was stabilized, the drug was added, and the drug was washed three times with nutrient solution every time the drug was changed. The drug concentration was the final concentration in the bath. Observe and record the highest muscle tension and number of contractions of the uterus within 10 minutes after administration, the results are shown in Table 3

表3加味益母丸对大鼠离体子宫肌张力的影响(x±s,n=10)Table 3 The effect of Jiawei Yimu Pill on rat isolated uterine muscle tension (x±s, n=10)

结果表明,加味益母丸能明显增强大鼠离体子宫收缩,并且有一定的量效关系,剂量增加收缩力增强且收缩频率加快。The results show that Jiawei Yimu Pill can significantly enhance the contraction of isolated rat uterus, and there is a certain dose-effect relationship, the contraction force is enhanced and the contraction frequency is accelerated as the dose increases.

4、对缩宫素所致大鼠离体子宫平滑肌收缩的影响4. Effects on contraction of rat isolated uterine smooth muscle induced by oxytocin

实验方法同3,待子宫活动平稳后,从浴槽上方加入0.05μg(浴槽终浓度为0.003μg/mL)缩宫素,子宫平滑肌开始收缩,并且能在最高处稳定30min,在缩宫素作用10min后加入加味益母丸,观察子宫收缩情况,结果见表4The experimental method is the same as 3. After the uterine activity is stable, add 0.05 μg (the final concentration of the bath is 0.003 μg/mL) oxytocin from the top of the bath, and the uterine smooth muscle begins to contract, and can be stable at the highest point for 30 minutes. Added Jiawei Yimu Pills to observe the uterine contraction, the results are shown in Table 4

表4加味益母丸对缩宫素所致大鼠离体子宫平滑肌收缩的影响(x±s,n=10)Table 4 Effects of Modified Yimu Pills on contraction of rat isolated uterine smooth muscle induced by oxytocin (x±s, n=10)

结果表明,当加入加味益母丸后子宫肌张力降低,有不同程度的抑制作用。The results showed that the tension of uterine muscle decreased after adding Jiawei Yimu Pills, and there were different degrees of inhibition.

5、临床研究数据5. Clinical research data

治疗组:加味益母丸,药物组成:益母草250g,当归30g,续断18g,杜仲15g,山药15g,阿胶45g,水冲服,3g/丸,一日2~3次,每次2丸。对照1组:益母草冲剂,15g/包,一日2次,每次1包。Treatment group: Jiawei Yimu Pills, drug composition: Leonurus 250g, Angelica 30g, Dipsacus 18g, Eucommia 15g, Chinese yam 15g, Ejiao 45g, mixed with water, 3g/pill, 2-3 times a day, 2 pills each time. Control group 1: motherwort granules, 15g/packet, 2 times a day, 1 packet each time.

对照2组:八珍益母丸(大蜜丸),9g/丸,一日2次,每次1丸。Control group 2: Bazhen Yimu Pills (Da Miwan), 9g/pill, 2 times a day, 1 pill each time.

纳入病例标准:①确诊为月经不调的患者。②年龄在25~45岁之间。③由主管医生确认在试验期间,如发生不良反应,不至于影响患者治疗者。④签署知情同意书。本临床研究至结束时共收到病例报告表186份。试验组62例,对照1组62例,对照2组62例,均为门诊病人。西医诊断为月经不调,中医辨证属于气滞血瘀证。Criteria for inclusion of cases: ①Patients diagnosed with irregular menstruation. ②Aged between 25 and 45 years old. ③ It is confirmed by the doctor in charge that during the trial period, if adverse reactions occur, it will not affect the patient's treatment. ④ Sign the informed consent form. A total of 186 case report forms were received by the end of this clinical study. There were 62 cases in the test group, 62 cases in the control group 1, and 62 cases in the control group 2, all of whom were outpatients. Western medicine diagnosis is irregular menstruation, and TCM syndrome differentiation belongs to Qi stagnation and blood stasis syndrome.

月经周期、量、色、质、持续时间及相关证侯的变化,以临床症状的改变为量化指标判定,结果如下表:Changes in menstrual cycle, quantity, color, quality, duration and related syndromes are judged by changes in clinical symptoms as quantitative indicators. The results are as follows:

三种药物治疗后小腹胀痛、神疲乏力、痛经等症状疗效比较,加味益母丸较其它两种有明显的优势,其症状消失率高出10%以上。Comparing the curative effects of the three medicines on symptoms such as abdominal pain, fatigue, and dysmenorrhea, Jiawei Yimu Pills has obvious advantages over the other two, and its symptom disappearance rate is more than 10% higher.

Claims (6)

1. a kind of Chinese medicine composition, it is characterised in that the active constituents of medicine of the Chinese medicine composition is motherwort, Radix Angelicae Sinensis, continued The disconnected, bark of eucommia, Chinese yam, donkey-hide gelatin.
2. Chinese medicine composition according to claim 1, it is characterised in that in parts by mass, the active constituents of medicine Bulk drug is matched:100~500 parts of motherwort, 20~40 parts of Radix Angelicae Sinensis, interrupted 15~20 parts, 10~20 parts of the bark of eucommia, Chinese yam 10~ 20 parts, 40~50 parts of donkey-hide gelatin.
3. Chinese medicine composition according to claim 1, it is characterised in that in parts by mass, the active constituents of medicine Bulk drug is matched:250 parts of motherwort, 30 parts of Radix Angelicae Sinensis, interrupted 18 parts, 15 parts of the bark of eucommia, 15 parts of Chinese yam, 45 parts of donkey-hide gelatin.
4. the Chinese medicine composition according to claims 1 to 3 any one, it is characterised in that described Chinese medicine composition is Oral agents.
5. the Chinese medicine composition according to claims 1 to 3 any one is preparing treatment hypoplasia of uterus, menstruation not Application in tune, amenorrhoea medicine.
6. a kind of prepare treatment hypoplasia of uterus, irregular menstruation, the method for amenorrhoea medicine, its step is:In parts by mass, take 100~500 parts of motherwort, 20~40 parts of Radix Angelicae Sinensis, interrupted 15~20 parts, 10~20 parts of the bark of eucommia, 10~20 parts of Chinese yam, donkey-hide gelatin 40~ 50 parts, it is sufficiently mixed uniformly, 800~1000 parts of refined honey is added while hot, high-speed stirred is uniform, and pill is produced.
CN201710096844.4A 2017-02-22 2017-02-22 A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation Pending CN107041921A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710096844.4A CN107041921A (en) 2017-02-22 2017-02-22 A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710096844.4A CN107041921A (en) 2017-02-22 2017-02-22 A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation

Publications (1)

Publication Number Publication Date
CN107041921A true CN107041921A (en) 2017-08-15

Family

ID=59544535

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710096844.4A Pending CN107041921A (en) 2017-02-22 2017-02-22 A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation

Country Status (1)

Country Link
CN (1) CN107041921A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185333A (en) * 1996-12-20 1998-06-24 许其宽 Womb-warming proconceptive powder
CN103566119A (en) * 2012-08-03 2014-02-12 天津太平洋制药有限公司 Drug for treating irregular menstruation and preparation method thereof
CN105412787A (en) * 2015-12-07 2016-03-23 李霞 Medicine for treating postpartum irregular menstruation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185333A (en) * 1996-12-20 1998-06-24 许其宽 Womb-warming proconceptive powder
CN103566119A (en) * 2012-08-03 2014-02-12 天津太平洋制药有限公司 Drug for treating irregular menstruation and preparation method thereof
CN105412787A (en) * 2015-12-07 2016-03-23 李霞 Medicine for treating postpartum irregular menstruation

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
303医院妇产科: ""妇科应用中药加味益母丸的临床疗效观察"", 《人民军医》 *
刘玺珍: "加味益母丸治疗不孕症 ", 《河北中医》 *
刘玺珍: "加味益母丸治疗不孕症", 《河北中医》 *
蔡琼英等: "《中药制剂汇编》", 31 August 1981, 中国人民解放军总后勤部卫生部 *

Similar Documents

Publication Publication Date Title
CN104381713A (en) Compound feeds for sheep and preparation method for compound feeds
CN102973829B (en) Feed for treating diarrhea of dairy cow
CN101703651A (en) Medicament for treating diabetic gangrene
CN102068616A (en) Medicament for treating gynecological diseases and preparation method
CN100556425C (en) A kind of Chinese medicine unguentum of analgetic, hemostatic repercussive and sore-arresting functions
CN107041921A (en) A kind of composition for being used to treat the diseases such as hypoplasia of uterus, irregular menstruation
CN105194361A (en) Traditional Chinese medicine composition for preventing and treating hemorrhagic disease of aquatic animals and preparation method thereof
CN101507807B (en) Traditional Chinese medicine composition capable of treating horse acute gastroenteritis
CN104523897A (en) Enteroclysis medicine composition for treating piglet epidemic diarrhea
CN103142751B (en) Traditional Chinese medicine composition for treating piglet iron-deficiency anemia
CN1969996A (en) Chinese medicinal powder having functions in stopping bleeding, relieving pain, diminishing swelling and promoting granulation and preparation process thereof
CN104606627B (en) A kind of pharmaceutical composition for treating grice diarrhoea and preparation method thereof
CN106860717A (en) It is a kind of to treat infertile medicine
CN105770448B (en) A kind of pharmaceutical composition and preparation method thereof preventing and treating perianal
CN104189167A (en) Cataplasm for treating piglet diarrhea and preparation method of cataplasm
CN110680849B (en) Oral traditional Chinese medicine formula for treating fracture
CN116549522B (en) Application of traditional Chinese medicine composition in gout
CN101708284B (en) Medicament for treating hemorrhoids
CN108420855B (en) Pharmaceutical composition for preventing and treating dysmenorrhea
CN107007725A (en) A kind of Shi Yi Fang vinum formula and preparation method thereof
CN107496532A (en) A kind of Chinese medicine composition for treating chicken dysentery and preparation method thereof
CN1939469A (en) Chinese medicinal plaster with analgetic, hemostatic, repercussive and sarcogenic functions
CN106798864B (en) A Chinese medicinal composition for treating internal diseases
CN104474194A (en) Traditional Chinese medicine preparation for treating angina and preparation method of traditional Chinese medicine preparation
CN108420847A (en) A kind of nonreactive composition and its preparation method and application slowing down diarrhea of pigs

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170815

RJ01 Rejection of invention patent application after publication